Table 1 The clinicopathological characteristics of the ARDS survivors
Variable | Mean (SD) or N (%) |
|---|---|
Age, year | 66.0 (17.2) |
Sex, male | 4180 (61.4) |
Having a job at admission for ARDS | 3555 (52.2) |
Annual income level at ARDS treatment | |
 Q1 (Lowest) | 2031 (29.8) |
 Q2 | 1073 (15.8) |
 Q3 | 1333 (19.6) |
 Q4 (Highest) | 2227 (32.7) |
 Unknown | 145 (2.1) |
Admitting department | |
 IM | 5480 (80.5) |
 Non-IM | 1329 (19.5) |
Length of hospitalization, day | 20.7 (17.2) |
Total cost for hospitalization, USD | 10,799.2 (13,605.4) |
Annual case volume of ARDS admission | |
 Q1 ≤ 4 | 1417 (20.8) |
 Q2: 5–14 | 1648 (24.2) |
 Q3: 15–28 | 1966 (28.9) |
 Q4 ≥ 28 | 1778 (26.1) |
Main diagnosis of ARDS | 3390 (49.8) |
Sepsis associated ARDS | 393 (5.3) |
Diagnosis of shock during hospitalization | 363 (5.3) |
Underlying brain disability | 484 (7.1) |
Underlying non-brain disability | 1480 (21.7) |
Isolated ICU admission | 196 (2.9) |
CCI at hospital admission for ARDS | |
 0–1 | 1523 (22.4) |
 2–3 | 2171 (31.9) |
 4–5 | 1558 (22.9) |
 ≥ 6 | 1557 (22.9) |
ECMO support | 317 (4.7) |
NMB use | 2238 (32.9) |
CRRT use | 299 (4.4) |
Benzodiazepine continuous infusion | 3889 (57.1) |
Opioid continuous infusion | 1049 (15.4) |
Propofol continuous infusion | 560 (8.2) |
Duration of Mechanical Ventilator use, day | 4.6 (8.8) |
Experience of CPR during hospitalization | 236 (3.5) |
Concurrent other psychiatric illness | |
 Depression | 1866 (27.4) |
 Anxiety disorder | 2324 (34.1) |
 PTSD | 11 (0.2) |
 Alcohol abuse | 314 (4.6) |
 Other substance abuse | 36 (0.5) |
Year of admission for ARDS | |
 2010 | 849 (12.5) |
 2011 | 656 (9.6) |
 2012 | 607 (8.9) |
 2013 | 527 (7.7) |
 2014 | 641 (9.4) |
 2015 | 621 (9.1) |
 2016 | 831 (12.2) |
 2017 | 705 (10.4) |
 2018 | 723 (10.6) |
 2019 | 649 (9.5) |
1-year all-cause mortality | 1868 (27.4) |